Clearly visible on the chart triangle breakout, strong 2x and 6x volume spike today. On top of this - very positive sentiment news coming from famous bio stock trader biomedreports.com. RNN is clinical stage pharmaceutical investment biotech plays, has announced that it has enrolled two-thirds of the total patients needed for its Phase IIb clinical trial to study the safety and efficacy of Serdaxin to treat major depressive disorder. RNN began enrollment for the study earlier this year and plans to enroll a total of 300 patients. The trial is being conducted at 40 sites in the United States.... And by the way, our backtesting looks reliable too. What else do we need for a good run up higher tomorrow morning?
Symbol: RNN
Backtest Strategy: Pennystocks100 (5 min chart)
Period: May 9, 2010 - May 9, 2011
# Win: 4
# Loss: 0
Winners: 100%
Profit-Loss%: +13.44%
No comments:
Post a Comment